CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	3 Months Ended		9 Months Ended
	Oct. 30, 2021	Oct. 31, 2020	Oct. 30, 2021	Oct. 31, 2020
Income Statement [Abstract]
Net sales	$ 130,681,000	$ 109,025,000	$ 357,325,000	$ 329,374,000
Cost of sales	76,260,000	68,211,000	208,911,000	206,711,000
Gross profit	54,421,000	40,814,000	148,414,000	122,663,000
Operating expense:
Distribution and selling	39,302,000	31,490,000	108,907,000	97,100,000
General and administrative	10,746,000	4,687,000	24,569,000	15,158,000
Depreciation and amortization	9,741,000	7,977,000	24,727,000	16,700,000
Restructuring costs	634,000	55,000	634,000	264,000
Total operating expense	60,423,000	44,209,000	158,837,000	129,222,000
Operating loss	(6,002,000)	(3,395,000)	(10,423,000)	(6,559,000)
Other income (expense):
Interest income	85,000	1,000	124,000	2,000
Interest expense	(3,551,000)	(1,339,000)	(6,245,000)	(3,920,000)
Loss on debt extinguishment	(9,000)		(663,000)
Total other expense, net	(3,475,000)	(1,338,000)	(6,784,000)	(3,918,000)
Loss before income taxes	(9,477,000)	(4,733,000)	(17,207,000)	(10,477,000)
Income tax provision	(15,000)	(15,000)	(45,000)	(45,000)
Net loss	(9,492,000)	(4,748,000)	(17,252,000)	(10,522,000)
Less: Net loss attributable to non-controlling interest			(282,000)
Net loss attributable to shareholders	$ (9,492,000)	$ (4,748,000)	$ (16,970,000)	$ (10,522,000)
Net loss per common share	$ (0.44)	$ (0.39)	$ (0.91)	$ (1.05)
Net loss per common share - assuming dilution	$ (0.44)	$ (0.39)	$ (0.91)	$ (1.05)
Weighted average number of common shares outstanding:
Basic	21,503,340	12,177,990	18,710,658	10,000,383
Diluted	21,503,340	12,177,990	18,710,658	10,000,383